508 related articles for article (PubMed ID: 15452091)
1. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
2. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
Brooks SE; Gu X; Samuel S; Marcus DM; Bartoli M; Huang PL; Caldwell RB
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):222-8. PubMed ID: 11133872
[TBL] [Abstract][Full Text] [Related]
3. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
5. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Stitt AW; Graham D; Gardiner TA
Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
[TBL] [Abstract][Full Text] [Related]
6. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
7. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
8. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
9. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
10. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
11. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
12. Altered retinal neovascularization in TNF receptor-deficient mice.
Ilg RC; Davies MH; Powers MR
Curr Eye Res; 2005 Nov; 30(11):1003-13. PubMed ID: 16282134
[TBL] [Abstract][Full Text] [Related]
13. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.
Yoo MH; Hyun HJ; Koh JY; Yoon YH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979
[TBL] [Abstract][Full Text] [Related]
14. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
[TBL] [Abstract][Full Text] [Related]
15. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
16. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
Gendron RL; Good WV; Miskiewicz E; Tucker S; Phelps DL; Paradis H
Mol Vis; 2006 Feb; 12():108-16. PubMed ID: 16518308
[TBL] [Abstract][Full Text] [Related]
17. Transient exposure of rat pups to hyperoxia at normobaric and hyperbaric pressures does not cause retinopathy of prematurity.
Calvert JW; Zhou C; Zhang JH
Exp Neurol; 2004 Sep; 189(1):150-61. PubMed ID: 15296845
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy.
McLeod DS; D'Anna SA; Lutty GA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1918-32. PubMed ID: 9727415
[TBL] [Abstract][Full Text] [Related]
19. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
Zhang ZH; Jiang L; Qiao LX
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
[TBL] [Abstract][Full Text] [Related]
20. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]